Investment
Features
FeesSafety
Academy
More
Pluang+

Doximity rated a buy for strong growth, low risk, and solid cash flow despite near-term earnings concerns.

Analyst Insights
21 Oct 2026
Seeking Alpha
View Source
Bullish
Doximity rated a buy for strong growth, low risk, and solid cash flow despite near-term earnings concerns.

Doximity, a healthcare AI platform, received a buy rating from analyst Albert Anthony, who highlights its strong revenue growth, low leverage risk, competitive position, and positive operating cash flow trends. The platform is widely used by top medical customers, supporting its long-term growth potential. However, near-term earnings forecasts and valuation present some risks. The rating challenges the more neutral consensus, betting on Doximity's future expansion rather than short-term performance.

Doximity and its AI-driven medical platform are the focus, with this data providing market context. As of Oct 21, 2026 20:51 WIB, 100 of 150 priced Health-sector US stocks on Pluang rose while 46 fell. Notable movers include TNGX at USD 27.19 with a 7.68% increase, ENVB at USD 1.55 up 7.64%, and ROIV at USD 36.90 gaining 5.67%.

More News

Winnebago Q4 revenue drops 17% but beats EPS estimates, shares rise 6%.

Winnebago Q4 revenue drops 17% but beats EPS estimates, shares rise 6%.

Winnebago Industries reported Q4 2026 earnings with revenue of $645.1 million, down 17% year-over-year due to fewer unit sales and product mix changes, missing estimates. However, adjusted earnings per share beat expectations at $0.49 versus $0.47 es...

Company Fundamentals
Neutral
52 minutes ago
Liberty Energy set to report Q3 2026 earnings with revenue forecast at $1.19B amid mixed cost and pricing pressures

Liberty Energy set to report Q3 2026 earnings with revenue forecast at $1.19B amid mixed cost and pricing pressures

Liberty Energy will report its Q3 2026 earnings on October 21, with Wall Street expecting earnings per share between $0.06 and $0.11 and revenue around $1.19 billion. The company benefits from strong fleet utilization and improved pricing, especially...

Company Fundamentals
Neutral
56 minutes ago
Global oral drugs market to exceed $1 trillion by 2034, driven by chronic disease demand and new therapies.

Global oral drugs market to exceed $1 trillion by 2034, driven by chronic disease demand and new therapies.

The global oral drugs market is projected to surpass $1 trillion by 2034, growing at about 6% annually. Growth is fueled by rising chronic diseases, patient preference for convenient oral treatments, and advances in drug delivery technologies. North ...

Market News
Bullish
56 minutes ago
Notified launches beta for AI-powered PR and IR data access via Microsoft Teams and Copilot.

Notified launches beta for AI-powered PR and IR data access via Microsoft Teams and Copilot.

Notified has introduced a beta program for its Model Context Protocol (MCP), enabling public relations and investor relations professionals to access and interact with their data through AI agents like Microsoft Teams and Copilot. This integration al...

Others
Bullish
56 minutes ago
JetBlue and Virgin Voyages launch a kid-free vacation combining adult-only flights and cruises.

JetBlue and Virgin Voyages launch a kid-free vacation combining adult-only flights and cruises.

JetBlue Vacations and Virgin Voyages have introduced "Do Not Disturb," a unique vacation package offering a kid-free experience from flight to cruise. Starting with an adults-only JetBlue flight from New York to Florida and continuing with a Virgin V...

Market News
Bullish
1 hour ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App